BNTX - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against BioNTech SE (BNTX) | Benzinga

NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all persons or entities who purchased or otherwise acquired BioNTech SE ("BioNTech" or the "Company") (NASDAQ:BNTX) securities between March 30, 2022 and October 13, 2023, inclusive (the "Class Period").

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (i) BioNTech overstated demand for Comirnaty and/or its commercial prospects; (ii) the Company and/or Pfizer had accumulated excess inventory of raw materials for Comirnaty, as well as COVID-19 vaccine doses ...

BNTX)>Full story available on Benzinga.com